Feline diabetes pill gets FDA green lightDecember 9, 2022Bexacat has been approval by the U.S. Food and Drug Administration (FDA) for improved glycemic control in diabetic cats. Developed by Elanco Animal Health, the oral medication, which contains the active ingredient bexagliflozin, marks the first sodium-glucose cotransporter 2 (SGLT2) inhibitor (i.e. not insulin) approved by FDA in any animal species, the agency reports.
SPONSORED CONTENTImprove their microbiome, improve quality of lifeWith 70% of a dog’s immune system in the GI tract, you need confidence in their microbiome support — which is why Hill’s developed ActivBiome+. + Learn More
